Bioqual, Inc.
BIOQ · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $40,249 | $64,912 | $68,281 | $62,609 |
| - Cash | $17,853 | $15,594 | $7,279 | $2,184 |
| + Debt | $16,541 | $3,587 | $18,608 | $18,725 |
| Enterprise Value | $38,936 | $52,905 | $79,610 | $79,150 |
| Revenue | $48,868 | $58,591 | $62,664 | $66,150 |
| % Growth | -16.6% | -6.5% | -5.3% | – |
| Gross Profit | -$1,896 | $7,429 | $12,605 | $13,005 |
| % Margin | -3.9% | 12.7% | 20.1% | 19.7% |
| EBITDA | $510 | $3,032 | $6,968 | $14,762 |
| % Margin | 1% | 5.2% | 11.1% | 22.3% |
| Net Income | -$1,048 | $483 | $836 | $5,261 |
| % Margin | -2.1% | 0.8% | 1.3% | 8% |
| EPS Diluted | -1.17 | 0.54 | 0.93 | 5.88 |
| % Growth | -316.7% | -41.9% | -84.2% | – |
| Operating Cash Flow | $2,945 | $9,359 | $8,230 | $313 |
| Capital Expenditures | -$239 | -$597 | -$2,242 | -$4,885 |
| Free Cash Flow | $2,706 | $8,762 | $5,988 | -$4,572 |